• Vaccinex stock soars 223% on partnership deals using its antibody discovery platform

    11 days ago - By Business Insider

    Vaccinex shares were up as much as 223% Friday on two project deals with pharmaceutical companies.
    Trading volume of 196 million shares outpaced the average daily volume of about 540,000.
    The company did not disclose the value of the two deals.
    Visit the Business section of Insider for more stories .
    Vaccinex stock rocketed up more than 200% Friday, propelled by two collaboration deals centered on using the biotech company's antibody discovery platform. Vaccinex, which focuses on cancer and neurodegenerative disease, said it signed multi-project deals with two unnamed "prominent...
    Read more ...